Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News

IDEAYA and Servier's Eye Cancer Drug Meets Trial Goal, Paving Way for FDA Application

IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of ⁠eye cancer met the main goal of a mid-to-late-stage trial, sending...

Lung Test May Predict Transition From Early to Definite SSc

A lower initial lung diffusion capacity for carbon monoxide is associated with a higher rate of progression from very early diagnosis to definite systemic sclerosis.

Oral JAK1 Inhibitor Povorcitinib Shows Promise in HS

Abscesses and nodules improve significantly at 12 and 54 weeks.

Predictors of Rare Form of Crohn’s Disease Identified

Perianal disease involvement and a history of an ostomy are associated with increased odds of developing metastatic cutaneous Crohn’s disease.

Cosmetic Eyelash Extensions Linked to Dry Eye Symptoms

Eye symptoms affect most recipients of lash lifts and extensions, with an independent association with dry eye in an observational study.

FDA Approves Radiesse Filler for Decolletage Wrinkles

An agency advisory committee in 2025 recommended more study of fillers in that body area to address potential safety concerns.

Todays Updates

Early Multimodal Therapy Restores Hairline in a Woman

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

Primary Care on the Front Lines of Mental Health Care

With a mental health care provider shortage and many patients’ seeking mental health support, primary care doctors have stepped up to the front lines.

Strategies for Latent TB Infection Screening and Care

While tuberculosis spread is not significant nationally, lack of awareness of the latent form of the condition raises legitimate concerns for potential future infections.

Global Fund Expands Commitment to Improve Access to HIV Drug

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

Funding Cuts Challenge Malaria Vaccination Initiatives

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

HIV Treatment May Move Beyond Daily Pills With Injectables

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

Todays Updates

Early Multimodal Therapy Restores Hairline in a Woman

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

Primary Care on the Front Lines of Mental Health Care

With a mental health care provider shortage and many patients’ seeking mental health support, primary care doctors have stepped up to the front lines.

Strategies for Latent TB Infection Screening and Care

While tuberculosis spread is not significant nationally, lack of awareness of the latent form of the condition raises legitimate concerns for potential future infections.

Global Fund Expands Commitment to Improve Access to HIV Drug

The U.S. and the Global Fund to Fight AIDS, Tuberculosis and Malaria are stepping up efforts to ⁠broaden access to Gilead's HIV prevention drug, with a goal of reaching 3...

Funding Cuts Challenge Malaria Vaccination Initiatives

Fewer resources through Gavi, the Vaccine Alliance, may limit vaccine administration at the local level.

HIV Treatment May Move Beyond Daily Pills With Injectables

Monthly injectable HIV therapy shows lower treatment failure than oral regimens in individuals with adherence challenges.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

Latest News

IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of ⁠eye cancer met the main goal of a mid-to-late-stage trial, sending...

A lower initial lung diffusion capacity for carbon monoxide is associated with a higher rate of progression from very early diagnosis to definite systemic sclerosis.

Abscesses and nodules improve significantly at 12 and 54 weeks.

Perianal disease involvement and a history of an ostomy are associated with increased odds of developing metastatic cutaneous Crohn’s disease.

Eye symptoms affect most recipients of lash lifts and extensions, with an independent association with dry eye in an observational study.

An agency advisory committee in 2025 recommended more study of fillers in that body area to address potential safety concerns.

News All Time

Weight-Loss Drug-Biologic Combo Boosts Relief in PsA

ACR50 scores improve when tirzepatide is added to ixekizumab in higher-BMI group, in two trials.

CLL Tied to Increased Skin Cancer Risk Over 10 Years

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and death.

TYK2 inhibitor Promising for Psoriasis in Phase 3 Studies

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety concerns emerging.

EU Backs Targeted BRAF Combo in Melanoma, Thyroid Cancer

European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and extended its use to adolescents with advanced or resected melanoma.

Incyte's Skin Disease Drug Shows Long-term Symptom Relief in Late-stage Trials

Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in ⁠two late-stage trials.

Superficial Radiation Tx Costs Exceed Mohs Surgery for NMSC

Image-guided superficial radiation therapy remains a higher-cost treatment than Mohs surgery for nonmelanoma skin cancer, a retrospective study shows.

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

Research Uncovers Mental Health Toll of Alopecia on Women

Black women are at greater risk for depression and anxiety, and scarring forms are linked to more disorders.

ICI-Related Toxicity Diagnoses Differ for Dark vs Light Skin

A review of published studies suggests that skin toxicities related to checkpoint inhibitors may be managed differently in patients with skin of color vs lighter skin tones.

Consensus Defines Vitiligo Severity, Relapse Beyond BSA

An international consensus study establishes standardized definitions for vitiligo severity and relapse, emphasizing that body surface area alone is insufficient to capture disease burden.

First-Line Biologics May Improve Psoriasis Outcomes

Biologics as a first-line systemic therapy are associated with better clinical outcomes and lower risks for chronic comorbidities in patients with moderate-to-severe psoriasis.

Pfizer-Valneva Lyme Vaccine Shows More Than 70% Efficacy but Misses Key Goal

Pfizer and Valneva said on Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, ⁠even as it missed its main goal.

Can Mpox Vaccine Immunity Last for 5 Years?

The modified vaccinia Ankara-Bavarian Nordic vaccine induces sustained immune memory for up to 5 years, and a single booster dose at 5 years sharply raises antibody levels, a prospective study shows.

FDA Approves Dermal Filler for Temple Hollowing Indication

Loss of temple volume may be accelerated in people rapidly losing weight with medication.

Recommended News For You

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

FDA Approves Hemophilia B Second Gene Therapy.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors

AI is equally capable of reading breast cancer scans as human radiologists.

Recommended Articles For You

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment 

Advancements in Cancer Treatment and Survival Outcomes for Acute Myeloid Leukemia 

Hemoglobin C: Understanding its Role in Sickle Cell Disease 

Case Study: Genomic Medicine in Precision Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study reveals that older women frequently receive an incorrect breast cancer diagnosis.

2.

Combination therapy improves outcomes for advanced triple-negative breast cancer

3.

Ketamine plus psychotherapy for "excellent" PTSD

4.

Survey: Record Numbers of US Adults Report Depression.

5.

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

1.

The Latest Research on Acute Promyelocytic Leukemia: Advancements in Diagnosis and Therapy 

2.

A Closer Look at Breast Cancer: Examining the Ultrasound Images

3.

Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies

4.

Unlocking the Potential of CPK Levels: How to Maximize Your Health Benefits

5.

Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

5.

Updates on Standard V/S High Risk Myeloma Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot